Burzynski Research Institute Inc (BZYR) financial statements (2020 and earlier)

Company profile

Business Address 12000 RICHMOND AVE
HOUSTON, TX 77082
State of Incorp. DE
Fiscal Year End February 28
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

11/30/2019
TTM
2/28/2019
2/28/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Prepaid expense000    
Other undisclosed current assets   0   
Total current assets:0000000
Noncurrent Assets
Property, plant and equipment    000
Total noncurrent assets:    000
TOTAL ASSETS:0000000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0000000
Accounts payable0000000
Accrued liabilities0000000
Total current liabilities:0000000
Noncurrent Liabilities
Total liabilities:0000000
Stockholders' equity
Stockholders' equity attributable to parent(0)(0)(0)(0)(0)(0)(0)
Common stock0000000
Additional paid in capital123122120119117115112
Accumulated deficit(123)(122)(120)(119)(117)(115)(112)
Total stockholders' equity:(0)(0)(0)(0)(0)(0)(0)
TOTAL LIABILITIES AND EQUITY:0000000

Income statement (P&L) ($ in millions)

11/30/2019
TTM
2/28/2019
2/28/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
Operating expenses(2)(2)(2)(2)(2)(3)(4)
Operating loss:(2)(2)(2)(2)(2)(3)(4)
Nonoperating income
(Other Nonoperating income)
  0  0 
Net loss available to common stockholders, diluted:(2)(2)(2)(2)(2)(3)(4)

Comprehensive Income ($ in millions)

11/30/2019
TTM
2/28/2019
2/28/2018
2/28/2017
2/29/2016
2/28/2015
2/28/2014
Net loss:(2)(2)(2)(2)(2)(3)(4)
Comprehensive loss, net of tax, attributable to parent:(2)(2)(2)(2)(2)(3)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: